Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows 
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit 
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease 
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes 
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny 
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable” 
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
AFT Leaves X Over AI-Generated Images of Minors 
Starlink Internet Remains Active in Iran Despite Nationwide Blackout 
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026 
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures 
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration 
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests 
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules 
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds 
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle 
LAGUNA HILLS, Calif., March 30, 2017 -- Sonendo® Inc. the developer of a breakthrough technology for the dental marketplace, announced today that it will be presenting at the upcoming Needham Healthcare Conference in New York, NY on Wednesday, April 5th, 2017.
The Company’s presentation, to be delivered by President and CEO, Bjarne Bergheim, is scheduled for 10:00 a.m. Eastern Time. About the event, Bjarne Bergheim stated, “We look forward to participating in this year's conference and providing an update on the commercial activation of our GentleWave® System. This includes a presentation of results from both the GentleWave® patient and provider experience as we continue to pursue our mission of Saving Teeth Through Sound Science®.”
About Sonendo
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave® System, available in the US, shows significant improvements in clinical efficacy, and treatment efficiency when compared to standard root canal techniques1-2. For more information, please visit www.sonendo.com.
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05.
Forward-Looking Statements
This announcement contains forward-looking statements based on management's beliefs, assumptions, and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
Media Contact: Bob Guyatt Vice President of Marketing 949.766.3636
